Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 25, 2026
Impact of Early-Line Systemic Therapies on Liver Function in Hepatocellular Carcinoma: Longitudinal Change of ALBI Score and Ammonia Level With and Without Anti-VEGF AgentsNaoshi Nishida, Kazuomi Ueshima, Tomoko Aoki, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmaskingNaoshi Nishida, Hirokazu Chishina, Tadaaki Arizumi, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2017
Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus InfectionHiroshi Ida, Satoru Hagiwara, Masashi Kono, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
US-US Fusion Imaging in Radiofrequency Ablation for Liver MetastasesYasunori Minami, Tomohiro Minami, Hirokazu Chishina, et al.
Oncology|November 28, 2014
Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imagingTomohiro Minami, Yasunori Minami, Hirokazu Chishina, et al.
Oncology|November 28, 2014
Validation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJTadaaki Arizumi, Kazuomi Ueshima, Hirokazu Chishina, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2Naoshi Nishida, Masashi Kono, Tomohiro Minami, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinomaTadaaki Arizumi, Kazuomi Ueshima, Hirokazu Chishina, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrenceMasashi Kono, Tatsuo Inoue, Masatoshi Kudo, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenibTadaaki Arizumi, Kazuomi Ueshima, Hirokazu Chishina, et al.
Pageof 6